Healthy Returns: Novo Nordisk’s head of research and development previews the first-ever obesity pill ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Martin Holst Lange
since
auto-detected in 1 stories
7 months ago
Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up scientific discovery.
page 1 of 1